Table 5.

Descriptive statistics for subgroups based on symptom importance

	Subgroup 1			Subgroup 2			Subgroup 3
Symptom Importance	Estimated Marginal Means	S.E.	Range	Estimated Marginal Means	S.E.	Range	Estimated Marginal Means	S.E.	Range
Urination problems	2.32	0.58	0–10	4.51	0.66	0–9	6.59	0.82	0–10
Diarrhea	0.88	0.66	0–10	3.59	0.72	0–9	7.49	0.77	0–6
Constipation	1.35	0.87	0–5	5.43	0.97	0–9	5.88	0.89	0–10
Sexual dysfunction	3.22	0.67	0–10	4.35	0.76	0–10	7.86	1.02	0–10
Fatigue	2.11	0.29	0–10	6.64	0.34	0–10	8.71	0.44	0–10
Sleep problems	1.91	0.36	0–10	4.95	0.42	0–9	7.71	0.56	0–10
Pain	1.32	0.33	0–10	5.94	0.35	0–10	9.00	0.45	0–10
Nausea	0.98	1.36	0–3	4.85	0.92	0–9	9.00	1.73	0–10
Lack of appetite	2.97	0.96	0–8	3.44	0.90	0–7	7.58	0.85	0–10
Emotional distress	1.60	0.36	0–9	2.92	0.36	0–10	8.70	0.46	0–10
Differing Variables	Mean	SD	Range	Mean	SD	Range	Mean	SD	Range
Functional status	0.67	0.64	0–3	0.73	0.91	0–3	1.00	0.91	0–3
Fatigue	3.62	2.52	0–9	3.39	2.52	0–8	4.00	2.72	0–10
Sleep problems	2.86	2.61	0–9	2.70	2.62	0–8	2.72	2.24	0–7
Pain	2.02	2.33	0–8	1.91	2.59	0–8	2.17	2.64	0–7
Emotional distress	1.30	2.04	0–8	1.06	1.78	0–7	1.83	2.62	0–8
	n	(%)		n	(%)		n	(%)
History of pain treatment	9	20.93%		9	27.27%		5	27.78%

Subgroup 1 Low Symptom Importance, n = 43; Subgroup 2 Moderate Symptom Importance, n = 33; Subgroup 3 High Symptom Importance, n = 18.